

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hemidesmosome assembly (GO:0031581) | 6.52802213 |
| 2 | mesodermal cell differentiation (GO:0048333) | 6.40110774 |
| 3 | modulation by symbiont of host defense response (GO:0052031) | 6.38942912 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.38942912 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.38942912 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.38942912 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 6.38942912 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 6.38942912 |
| 9 | skin morphogenesis (GO:0043589) | 6.37317691 |
| 10 | metanephric nephron epithelium development (GO:0072243) | 5.30979099 |
| 11 | protein localization to endosome (GO:0036010) | 5.04274880 |
| 12 | protein maturation by protein folding (GO:0022417) | 4.98513178 |
| 13 | COPI coating of Golgi vesicle (GO:0048205) | 4.90265667 |
| 14 | Golgi transport vesicle coating (GO:0048200) | 4.90265667 |
| 15 | metanephric epithelium development (GO:0072207) | 4.89970068 |
| 16 | metanephric tubule development (GO:0072170) | 4.83128400 |
| 17 | metanephric nephron tubule development (GO:0072234) | 4.83128400 |
| 18 | cell adhesion mediated by integrin (GO:0033627) | 4.62417860 |
| 19 | hypotonic response (GO:0006971) | 4.61402258 |
| 20 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.53650150 |
| 21 | macrophage activation involved in immune response (GO:0002281) | 4.41069517 |
| 22 | protein retention in ER lumen (GO:0006621) | 4.33126502 |
| 23 | endodermal cell differentiation (GO:0035987) | 4.30866296 |
| 24 | urate metabolic process (GO:0046415) | 4.27740603 |
| 25 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.26194895 |
| 26 | toxin transport (GO:1901998) | 4.25920308 |
| 27 | microglial cell activation (GO:0001774) | 4.25548391 |
| 28 | barbed-end actin filament capping (GO:0051016) | 4.25466287 |
| 29 | membrane raft organization (GO:0031579) | 4.25318959 |
| 30 | lung vasculature development (GO:0060426) | 4.13861609 |
| 31 | regulation of metalloenzyme activity (GO:0048552) | 4.09850607 |
| 32 | response to peptidoglycan (GO:0032494) | 4.07089745 |
| 33 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.04816774 |
| 34 | response to host immune response (GO:0052572) | 4.04816774 |
| 35 | excretion (GO:0007588) | 3.99200213 |
| 36 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.91814598 |
| 37 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.85920908 |
| 38 | organic cation transport (GO:0015695) | 3.79113555 |
| 39 | nephron epithelium development (GO:0072009) | 3.77204477 |
| 40 | cellular copper ion homeostasis (GO:0006878) | 3.73013118 |
| 41 | wound healing, spreading of epidermal cells (GO:0035313) | 3.71380689 |
| 42 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.63956811 |
| 43 | cell-substrate junction assembly (GO:0007044) | 3.63226437 |
| 44 | * muscle cell migration (GO:0014812) | 3.63000294 |
| 45 | response to host (GO:0075136) | 3.60756334 |
| 46 | response to host defenses (GO:0052200) | 3.60756334 |
| 47 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.60756334 |
| 48 | drug transport (GO:0015893) | 3.60432664 |
| 49 | drug transmembrane transport (GO:0006855) | 3.57548109 |
| 50 | extracellular fibril organization (GO:0043206) | 3.52714680 |
| 51 | type B pancreatic cell proliferation (GO:0044342) | 3.52255928 |
| 52 | nephron tubule development (GO:0072080) | 3.46626244 |
| 53 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.38865902 |
| 54 | endothelial cell chemotaxis (GO:0035767) | 3.33262207 |
| 55 | substrate-dependent cell migration (GO:0006929) | 3.32457755 |
| 56 | protein hydroxylation (GO:0018126) | 3.28937039 |
| 57 | cellular response to vitamin (GO:0071295) | 3.24945059 |
| 58 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.23382298 |
| 59 | mammary gland epithelial cell proliferation (GO:0033598) | 3.23152855 |
| 60 | cellular response to vitamin D (GO:0071305) | 3.22943661 |
| 61 | actin filament depolymerization (GO:0030042) | 3.22037152 |
| 62 | renal absorption (GO:0070293) | 3.21793806 |
| 63 | chondrocyte proliferation (GO:0035988) | 3.18963886 |
| 64 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.17881782 |
| 65 | fibril organization (GO:0097435) | 3.17596988 |
| 66 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.15210587 |
| 67 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.14458296 |
| 68 | regulation of mononuclear cell migration (GO:0071675) | 3.13081803 |
| 69 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.10039188 |
| 70 | renal tubule development (GO:0061326) | 3.07649956 |
| 71 | response to gravity (GO:0009629) | 3.07636742 |
| 72 | apoptotic cell clearance (GO:0043277) | 3.07143124 |
| 73 | polyol transport (GO:0015791) | 3.05766984 |
| 74 | I-kappaB phosphorylation (GO:0007252) | 3.04959044 |
| 75 | positive regulation of actin filament depolymerization (GO:0030836) | 3.04788783 |
| 76 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.03010441 |
| 77 | neutrophil activation involved in immune response (GO:0002283) | 3.02604242 |
| 78 | regulation of glomerular filtration (GO:0003093) | 3.02420852 |
| 79 | vitamin D metabolic process (GO:0042359) | 3.02375582 |
| 80 | desmosome organization (GO:0002934) | 3.02361741 |
| 81 | positive regulation of heat generation (GO:0031652) | 2.99052507 |
| 82 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.97876172 |
| 83 | positive regulation of bone resorption (GO:0045780) | 2.95482329 |
| 84 | positive regulation of bone remodeling (GO:0046852) | 2.95482329 |
| 85 | glycoside metabolic process (GO:0016137) | 2.94863670 |
| 86 | detection of molecule of bacterial origin (GO:0032490) | 2.94741048 |
| 87 | positive regulation of interferon-alpha production (GO:0032727) | 2.93819886 |
| 88 | nuclear envelope reassembly (GO:0031468) | 2.92217771 |
| 89 | mitotic nuclear envelope reassembly (GO:0007084) | 2.92217771 |
| 90 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.91862505 |
| 91 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.91765005 |
| 92 | membrane protein ectodomain proteolysis (GO:0006509) | 2.90380023 |
| 93 | response to thyroid hormone (GO:0097066) | 2.88208491 |
| 94 | negative regulation of anoikis (GO:2000811) | 2.87135629 |
| 95 | macrophage activation (GO:0042116) | 2.84644983 |
| 96 | regulation of interferon-alpha production (GO:0032647) | 2.84495722 |
| 97 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.83467201 |
| 98 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.80073201 |
| 99 | stress fiber assembly (GO:0043149) | 2.79408204 |
| 100 | positive regulation of macrophage cytokine production (GO:0060907) | 2.78920601 |
| 101 | pinocytosis (GO:0006907) | 2.78659801 |
| 102 | negative regulation of stem cell proliferation (GO:2000647) | 2.77873641 |
| 103 | respiratory tube development (GO:0030323) | 2.77265316 |
| 104 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.75053653 |
| 105 | positive regulation of astrocyte differentiation (GO:0048711) | 2.73680723 |
| 106 | adhesion of symbiont to host cell (GO:0044650) | 2.72943998 |
| 107 | virion attachment to host cell (GO:0019062) | 2.72943998 |
| 108 | epithelial cell-cell adhesion (GO:0090136) | 2.71759501 |
| 109 | oligosaccharide catabolic process (GO:0009313) | 2.71605254 |
| 110 | glomerular basement membrane development (GO:0032836) | 2.71434030 |
| 111 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.70947058 |
| 112 | regulation of collagen metabolic process (GO:0010712) | 2.70139840 |
| 113 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.69392139 |
| 114 | positive regulation of osteoblast proliferation (GO:0033690) | 2.68362830 |
| 115 | endothelial tube morphogenesis (GO:0061154) | 2.68293061 |
| 116 | morphogenesis of an endothelium (GO:0003159) | 2.68293061 |
| 117 | collagen metabolic process (GO:0032963) | 2.67906772 |
| 118 | wound healing, spreading of cells (GO:0044319) | 2.66665570 |
| 119 | cortical actin cytoskeleton organization (GO:0030866) | 2.66617953 |
| 120 | response to vitamin D (GO:0033280) | 2.66452443 |
| 121 | ganglion development (GO:0061548) | 2.66386321 |
| 122 | copper ion homeostasis (GO:0055070) | 2.65467088 |
| 123 | adhesion of symbiont to host (GO:0044406) | 2.65329606 |
| 124 | establishment of viral latency (GO:0019043) | 2.64225226 |
| 125 | phosphate ion transport (GO:0006817) | 2.63470274 |
| 126 | keratan sulfate catabolic process (GO:0042340) | 2.63152650 |
| 127 | extracellular matrix disassembly (GO:0022617) | 2.62656565 |
| 128 | positive regulation of pseudopodium assembly (GO:0031274) | 2.61619826 |
| 129 | monocyte chemotaxis (GO:0002548) | 2.61463177 |
| 130 | endothelium development (GO:0003158) | 2.60808588 |
| 131 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.60657358 |
| 132 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.59683748 |
| 133 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.58893008 |
| 134 | collagen catabolic process (GO:0030574) | 2.58726393 |
| 135 | keratinocyte proliferation (GO:0043616) | 2.58572701 |
| 136 | endothelial cell morphogenesis (GO:0001886) | 2.58018179 |
| 137 | negative regulation of interleukin-17 production (GO:0032700) | 2.57870856 |
| 138 | response to muramyl dipeptide (GO:0032495) | 2.57482759 |
| 139 | response to mercury ion (GO:0046689) | 2.57378689 |
| 140 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.56530039 |
| 141 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.56377911 |
| 142 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.56003014 |
| 143 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.55095711 |
| 144 | response to hepatocyte growth factor (GO:0035728) | 2.55095711 |
| 145 | import into cell (GO:0098657) | 2.55059100 |
| 146 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.54254891 |
| 147 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.52317261 |
| 148 | endocardial cushion development (GO:0003197) | 2.51627389 |
| 149 | peptidyl-proline hydroxylation (GO:0019511) | 2.51486121 |
| 150 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.50936209 |
| 151 | positive regulation of p38MAPK cascade (GO:1900745) | 2.50583044 |
| 152 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.49175346 |
| 153 | modulation by symbiont of host cellular process (GO:0044068) | 2.48792230 |
| 154 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.48720585 |
| 155 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.47352099 |
| 156 | hyaluronan catabolic process (GO:0030214) | 2.46610161 |
| 157 | establishment of integrated proviral latency (GO:0075713) | 2.46234344 |
| 158 | protein heterotrimerization (GO:0070208) | 2.46048098 |
| 159 | superoxide anion generation (GO:0042554) | 2.46011784 |
| 160 | regulation of macrophage cytokine production (GO:0010935) | 2.45912390 |
| 161 | regulation of fever generation (GO:0031620) | 2.45465676 |
| 162 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.45092519 |
| 163 | collecting duct development (GO:0072044) | 2.44254760 |
| 164 | regulation of heat generation (GO:0031650) | 2.44168557 |
| 165 | regulation of anoikis (GO:2000209) | 2.43994838 |
| 166 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.43630459 |
| 167 | positive regulation of positive chemotaxis (GO:0050927) | 2.42961446 |
| 168 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.42830873 |
| 169 | eosinophil chemotaxis (GO:0048245) | 2.42519849 |
| 170 | lung morphogenesis (GO:0060425) | 2.42486732 |
| 171 | glomerular visceral epithelial cell development (GO:0072015) | 2.42338913 |
| 172 | cortical cytoskeleton organization (GO:0030865) | 2.41739401 |
| 173 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.41302377 |
| 174 | lysine metabolic process (GO:0006553) | 2.41286192 |
| 175 | lysine catabolic process (GO:0006554) | 2.41286192 |
| 176 | myeloid cell activation involved in immune response (GO:0002275) | 2.41234772 |
| 177 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.40776133 |
| 178 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.39392098 |
| 179 | negative regulation of lipid storage (GO:0010888) | 2.38101146 |
| 180 | mannose metabolic process (GO:0006013) | 2.37954780 |
| 181 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.37664230 |
| 182 | decidualization (GO:0046697) | 2.36541472 |
| 183 | positive regulation of calcium ion import (GO:0090280) | 2.36208463 |
| 184 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.35462342 |
| 185 | regulation of macrophage chemotaxis (GO:0010758) | 2.32536007 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.51892446 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.77202071 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.50569576 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.44506113 |
| 5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.27264156 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.11267267 |
| 7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.06798381 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.02279318 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.82831426 |
| 10 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.80791069 |
| 11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.63360972 |
| 12 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.58082782 |
| 13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.53399646 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.46952548 |
| 15 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35366385 |
| 16 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.30582342 |
| 17 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.28435203 |
| 18 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.18126940 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.97332939 |
| 20 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.96658389 |
| 21 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.89166085 |
| 22 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.87503034 |
| 23 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.86495666 |
| 24 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.86146800 |
| 25 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.85330114 |
| 26 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.83491522 |
| 27 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.77855622 |
| 28 | CJUN_26792858_Chip-Seq_BT549_Human | 1.75854571 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.72901626 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.67927539 |
| 31 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.66963451 |
| 32 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.65783155 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.64868465 |
| 34 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.63123531 |
| 35 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.61994630 |
| 36 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.59243188 |
| 37 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.54708916 |
| 38 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.53985497 |
| 39 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.53773004 |
| 40 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.53341900 |
| 41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53323578 |
| 42 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.52446743 |
| 43 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.52132983 |
| 44 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.47008394 |
| 45 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.46843927 |
| 46 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.46510087 |
| 47 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.45761699 |
| 48 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.44985500 |
| 49 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.44985500 |
| 50 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.44675593 |
| 51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43838012 |
| 52 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43696139 |
| 53 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.43311115 |
| 54 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.42572016 |
| 55 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.40276888 |
| 56 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40234581 |
| 57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39030051 |
| 58 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.38924372 |
| 59 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.37428362 |
| 60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.36441904 |
| 61 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.35132425 |
| 62 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.34755231 |
| 63 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33798880 |
| 64 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.31939456 |
| 65 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.31939456 |
| 66 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.30682306 |
| 67 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.30347218 |
| 68 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.28414592 |
| 69 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.27867457 |
| 70 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24495131 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24310553 |
| 72 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.23303683 |
| 73 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.20260830 |
| 74 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18797298 |
| 75 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.17771106 |
| 76 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17191276 |
| 77 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.17186346 |
| 78 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.15933037 |
| 79 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.15290858 |
| 80 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.13815636 |
| 81 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13136242 |
| 82 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11839681 |
| 83 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.11468264 |
| 84 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.11370260 |
| 85 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.09488176 |
| 86 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07876098 |
| 87 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07647239 |
| 88 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.06208326 |
| 89 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06030119 |
| 90 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.05442239 |
| 91 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.05207735 |
| 92 | VDR_22108803_ChIP-Seq_LS180_Human | 1.03928735 |
| 93 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02518208 |
| 94 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02293754 |
| 95 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01530323 |
| 96 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.01516118 |
| 97 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.00568922 |
| 98 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98851582 |
| 99 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98314613 |
| 100 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97933596 |
| 101 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.97627911 |
| 102 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97050503 |
| 103 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96934792 |
| 104 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.96185932 |
| 105 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.96096437 |
| 106 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.95962761 |
| 107 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95068001 |
| 108 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94310545 |
| 109 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93818605 |
| 110 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.93599158 |
| 111 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91529913 |
| 112 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.91421095 |
| 113 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.89944947 |
| 114 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89781830 |
| 115 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.89700380 |
| 116 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.87866532 |
| 117 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.87800476 |
| 118 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.87663710 |
| 119 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.87663710 |
| 120 | SPI1_23127762_ChIP-Seq_K562_Human | 0.87656405 |
| 121 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.87381003 |
| 122 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.86731149 |
| 123 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.86006882 |
| 124 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84764353 |
| 125 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.84757523 |
| 126 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.84686873 |
| 127 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.84309557 |
| 128 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.83219525 |
| 129 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.83058867 |
| 130 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.82562920 |
| 131 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.82406217 |
| 132 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.82022926 |
| 133 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.81528341 |
| 134 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.81272597 |
| 135 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.80271505 |
| 136 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.80201923 |
| 137 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79491575 |
| 138 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.78814086 |
| 139 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78095693 |
| 140 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.77862509 |
| 141 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.77767667 |
| 142 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76821955 |
| 143 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.76700006 |
| 144 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.75830008 |
| 145 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75621280 |
| 146 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75041333 |
| 147 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.73770287 |
| 148 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.73770287 |
| 149 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72096291 |
| 150 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.71853153 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.05172037 |
| 2 | MP0003195_calcinosis | 3.48615600 |
| 3 | MP0002877_abnormal_melanocyte_morpholog | 3.30846007 |
| 4 | MP0005257_abnormal_intraocular_pressure | 3.28781302 |
| 5 | MP0003303_peritoneal_inflammation | 3.27996269 |
| 6 | MP0001958_emphysema | 3.11639226 |
| 7 | MP0003950_abnormal_plasma_membrane | 3.03344261 |
| 8 | MP0004043_abnormal_pH_regulation | 2.95960191 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.95915639 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.76629160 |
| 11 | MP0009840_abnormal_foam_cell | 2.65883931 |
| 12 | MP0004019_abnormal_vitamin_homeostasis | 2.61611382 |
| 13 | MP0003724_increased_susceptibility_to | 2.27046557 |
| 14 | MP0006054_spinal_hemorrhage | 2.26719617 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.22907518 |
| 16 | MP0001756_abnormal_urination | 2.21128087 |
| 17 | MP0002136_abnormal_kidney_physiology | 2.20409045 |
| 18 | MP0009643_abnormal_urine_homeostasis | 2.17039838 |
| 19 | MP0003136_yellow_coat_color | 2.09811051 |
| 20 | MP0001765_abnormal_ion_homeostasis | 2.09614881 |
| 21 | MP0006082_CNS_inflammation | 2.08302827 |
| 22 | MP0005360_urolithiasis | 2.03749539 |
| 23 | MP0003172_abnormal_lysosome_physiology | 2.03043417 |
| 24 | MP0005623_abnormal_meninges_morphology | 1.96311950 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.95019741 |
| 26 | MP0010368_abnormal_lymphatic_system | 1.93486994 |
| 27 | MP0005332_abnormal_amino_acid | 1.89267241 |
| 28 | MP0005275_abnormal_skin_tensile | 1.87308300 |
| 29 | MP0009053_abnormal_anal_canal | 1.83542272 |
| 30 | * MP0003436_decreased_susceptibility_to | 1.83207283 |
| 31 | MP0002998_abnormal_bone_remodeling | 1.81428549 |
| 32 | MP0009780_abnormal_chondrocyte_physiolo | 1.80891304 |
| 33 | MP0000762_abnormal_tongue_morphology | 1.79208570 |
| 34 | MP0005174_abnormal_tail_pigmentation | 1.77872697 |
| 35 | MP0001849_ear_inflammation | 1.76956768 |
| 36 | MP0000538_abnormal_urinary_bladder | 1.68378992 |
| 37 | MP0004272_abnormal_basement_membrane | 1.67543724 |
| 38 | * MP0002419_abnormal_innate_immunity | 1.65157771 |
| 39 | * MP0005164_abnormal_response_to | 1.52643649 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.49248197 |
| 41 | MP0002933_joint_inflammation | 1.48301845 |
| 42 | MP0010030_abnormal_orbit_morphology | 1.47019349 |
| 43 | MP0009764_decreased_sensitivity_to | 1.46320150 |
| 44 | * MP0005000_abnormal_immune_tolerance | 1.44391609 |
| 45 | MP0005409_darkened_coat_color | 1.42385406 |
| 46 | * MP0001533_abnormal_skeleton_physiology | 1.41697724 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.40082025 |
| 48 | MP0002148_abnormal_hypersensitivity_rea | 1.39132672 |
| 49 | MP0002254_reproductive_system_inflammat | 1.38712827 |
| 50 | MP0005636_abnormal_mineral_homeostasis | 1.37958348 |
| 51 | MP0009785_altered_susceptibility_to | 1.37520488 |
| 52 | MP0000343_altered_response_to | 1.36819483 |
| 53 | MP0000569_abnormal_digit_pigmentation | 1.36113917 |
| 54 | MP0001243_abnormal_dermal_layer | 1.34193721 |
| 55 | MP0000733_abnormal_muscle_development | 1.34085455 |
| 56 | MP0001216_abnormal_epidermal_layer | 1.33904093 |
| 57 | MP0000749_muscle_degeneration | 1.33519802 |
| 58 | * MP0003448_altered_tumor_morphology | 1.33020521 |
| 59 | MP0003279_aneurysm | 1.32369320 |
| 60 | MP0002168_other_aberrant_phenotype | 1.31031836 |
| 61 | MP0002332_abnormal_exercise_endurance | 1.28118358 |
| 62 | * MP0000751_myopathy | 1.27444019 |
| 63 | MP0004381_abnormal_hair_follicle | 1.24855353 |
| 64 | MP0001299_abnormal_eye_distance/ | 1.24854523 |
| 65 | MP0000579_abnormal_nail_morphology | 1.24823151 |
| 66 | MP0003091_abnormal_cell_migration | 1.24186345 |
| 67 | MP0000537_abnormal_urethra_morphology | 1.22732244 |
| 68 | MP0008260_abnormal_autophagy | 1.22655484 |
| 69 | MP0001835_abnormal_antigen_presentation | 1.21628980 |
| 70 | MP0005451_abnormal_body_composition | 1.20506203 |
| 71 | MP0000015_abnormal_ear_pigmentation | 1.19719080 |
| 72 | MP0005464_abnormal_platelet_physiology | 1.19064500 |
| 73 | MP0001790_abnormal_immune_system | 1.17157927 |
| 74 | MP0005387_immune_system_phenotype | 1.17157927 |
| 75 | MP0000465_gastrointestinal_hemorrhage | 1.15991522 |
| 76 | MP0002135_abnormal_kidney_morphology | 1.13716779 |
| 77 | MP0003329_amyloid_beta_deposits | 1.12713441 |
| 78 | MP0002896_abnormal_bone_mineralization | 1.11965418 |
| 79 | MP0003795_abnormal_bone_structure | 1.10833554 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 1.10687057 |
| 81 | MP0009278_abnormal_bone_marrow | 1.10521741 |
| 82 | MP0010386_abnormal_urinary_bladder | 1.08160007 |
| 83 | MP0003828_pulmonary_edema | 1.03857845 |
| 84 | MP0005508_abnormal_skeleton_morphology | 1.03690408 |
| 85 | MP0000534_abnormal_ureter_morphology | 1.02326050 |
| 86 | * MP0008469_abnormal_protein_level | 1.02185674 |
| 87 | * MP0005025_abnormal_response_to | 1.02152488 |
| 88 | * MP0001845_abnormal_inflammatory_respons | 1.00720393 |
| 89 | * MP0002452_abnormal_antigen_presenting | 1.00141460 |
| 90 | MP0002277_abnormal_respiratory_mucosa | 0.99605875 |
| 91 | * MP0000750_abnormal_muscle_regeneration | 0.99451572 |
| 92 | MP0002928_abnormal_bile_duct | 0.99188567 |
| 93 | MP0010234_abnormal_vibrissa_follicle | 0.98671661 |
| 94 | MP0003806_abnormal_nucleotide_metabolis | 0.97649991 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 0.94623822 |
| 96 | MP0000467_abnormal_esophagus_morphology | 0.94244272 |
| 97 | MP0001915_intracranial_hemorrhage | 0.93365185 |
| 98 | MP0000767_abnormal_smooth_muscle | 0.92664061 |
| 99 | MP0005165_increased_susceptibility_to | 0.92564035 |
| 100 | * MP0005390_skeleton_phenotype | 0.91996372 |
| 101 | MP0003045_fibrosis | 0.90944595 |
| 102 | MP0002098_abnormal_vibrissa_morphology | 0.90590266 |
| 103 | MP0005377_hearing/vestibular/ear_phenot | 0.90207168 |
| 104 | MP0003878_abnormal_ear_physiology | 0.90207168 |
| 105 | MP0003941_abnormal_skin_development | 0.89326935 |
| 106 | MP0003690_abnormal_glial_cell | 0.89302006 |
| 107 | MP0002295_abnormal_pulmonary_circulatio | 0.89014478 |
| 108 | MP0000627_abnormal_mammary_gland | 0.88584666 |
| 109 | MP0000604_amyloidosis | 0.88293568 |
| 110 | MP0004742_abnormal_vestibular_system | 0.88052356 |
| 111 | MP0010771_integument_phenotype | 0.87408528 |
| 112 | MP0004510_myositis | 0.87253815 |
| 113 | MP0003075_altered_response_to | 0.86519713 |
| 114 | MP0004883_abnormal_blood_vessel | 0.86246244 |
| 115 | MP0005503_abnormal_tendon_morphology | 0.85805143 |
| 116 | MP0001853_heart_inflammation | 0.85416661 |
| 117 | MP0004858_abnormal_nervous_system | 0.84555881 |
| 118 | MP0005501_abnormal_skin_physiology | 0.84378918 |
| 119 | MP0005023_abnormal_wound_healing | 0.83615231 |
| 120 | MP0003705_abnormal_hypodermis_morpholog | 0.82156912 |
| 121 | MP0002115_abnormal_skeleton_extremities | 0.82078281 |
| 122 | * MP0002723_abnormal_immune_serum | 0.81734731 |
| 123 | MP0001851_eye_inflammation | 0.81433003 |
| 124 | MP0004947_skin_inflammation | 0.81269856 |
| 125 | MP0001879_abnormal_lymphatic_vessel | 0.80470354 |
| 126 | MP0000013_abnormal_adipose_tissue | 0.79811564 |
| 127 | MP0005595_abnormal_vascular_smooth | 0.78429260 |
| 128 | MP0005310_abnormal_salivary_gland | 0.77349328 |
| 129 | MP0005166_decreased_susceptibility_to | 0.76316284 |
| 130 | * MP0000858_altered_metastatic_potential | 0.75985407 |
| 131 | MP0005621_abnormal_cell_physiology | 0.75918619 |
| 132 | MP0004233_abnormal_muscle_weight | 0.75705438 |
| 133 | MP0002089_abnormal_postnatal_growth/wei | 0.75239902 |
| 134 | * MP0005197_abnormal_uvea_morphology | 0.74701022 |
| 135 | MP0002060_abnormal_skin_morphology | 0.74099364 |
| 136 | MP0000249_abnormal_blood_vessel | 0.73866444 |
| 137 | MP0002796_impaired_skin_barrier | 0.73151960 |
| 138 | MP0001663_abnormal_digestive_system | 0.72708297 |
| 139 | MP0005330_cardiomyopathy | 0.72287145 |
| 140 | * MP0001614_abnormal_blood_vessel | 0.71520817 |
| 141 | MP0000759_abnormal_skeletal_muscle | 0.70940931 |
| 142 | MP0000371_diluted_coat_color | 0.69821165 |
| 143 | MP0002405_respiratory_system_inflammati | 0.69599821 |
| 144 | MP0000163_abnormal_cartilage_morphology | 0.69144411 |
| 145 | MP0001542_abnormal_bone_strength | 0.68190488 |
| 146 | MP0000613_abnormal_salivary_gland | 0.67885679 |
| 147 | MP0008007_abnormal_cellular_replicative | 0.67423500 |
| 148 | MP0005193_abnormal_anterior_eye | 0.66866752 |
| 149 | * MP0002177_abnormal_outer_ear | 0.66073390 |
| 150 | MP0002113_abnormal_skeleton_development | 0.63497835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Metabolic alkalosis (HP:0200114) | 6.68635492 |
| 2 | Hypokalemic alkalosis (HP:0001949) | 5.88256951 |
| 3 | Hypomagnesemia (HP:0002917) | 5.75369143 |
| 4 | Increased circulating renin level (HP:0000848) | 5.44855887 |
| 5 | Abnormality of chloride homeostasis (HP:0011422) | 5.38815944 |
| 6 | Hyperactive renin-angiotensin system (HP:0000841) | 5.36730161 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 5.16021697 |
| 8 | Polyuria (HP:0000103) | 5.10312381 |
| 9 | Abnormality of magnesium homeostasis (HP:0004921) | 4.95920125 |
| 10 | Abnormal urine output (HP:0012590) | 4.75801543 |
| 11 | Protrusio acetabuli (HP:0003179) | 4.63406765 |
| 12 | Tetany (HP:0001281) | 4.54567112 |
| 13 | Abnormality of renal excretion (HP:0011036) | 4.39969949 |
| 14 | Follicular hyperkeratosis (HP:0007502) | 4.10218987 |
| 15 | Polydipsia (HP:0001959) | 3.96776532 |
| 16 | Abnormal drinking behavior (HP:0030082) | 3.96776532 |
| 17 | Hyperaldosteronism (HP:0000859) | 3.82913011 |
| 18 | Dysostosis multiplex (HP:0000943) | 3.75253611 |
| 19 | Renal salt wasting (HP:0000127) | 3.68792466 |
| 20 | Increased cerebral lipofuscin (HP:0011813) | 3.66642855 |
| 21 | Fragile skin (HP:0001030) | 3.66282745 |
| 22 | Onycholysis (HP:0001806) | 3.57095521 |
| 23 | Achilles tendon contracture (HP:0001771) | 3.55559601 |
| 24 | Abnormality of renin-angiotensin system (HP:0000847) | 3.53200631 |
| 25 | Ankle contracture (HP:0006466) | 3.52950590 |
| 26 | Spinal rigidity (HP:0003306) | 3.50956339 |
| 27 | Fragile nails (HP:0001808) | 3.47304559 |
| 28 | Alkalosis (HP:0001948) | 3.43608305 |
| 29 | Milia (HP:0001056) | 3.38344949 |
| 30 | Mucopolysacchariduria (HP:0008155) | 3.30955004 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.30955004 |
| 32 | Short nail (HP:0001799) | 3.30197905 |
| 33 | Axonal loss (HP:0003447) | 3.29567134 |
| 34 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.20999442 |
| 35 | Abnormality of the Achilles tendon (HP:0005109) | 3.11141365 |
| 36 | Gout (HP:0001997) | 3.08684232 |
| 37 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.08504144 |
| 38 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.08504144 |
| 39 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.08504144 |
| 40 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.01654139 |
| 41 | Abnormality of macrophages (HP:0004311) | 3.00912737 |
| 42 | Type 1 muscle fiber predominance (HP:0003803) | 2.99068263 |
| 43 | Distal lower limb amyotrophy (HP:0008944) | 2.98115037 |
| 44 | Premature rupture of membranes (HP:0001788) | 2.95724613 |
| 45 | Renal tubular acidosis (HP:0001947) | 2.87402917 |
| 46 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.86753377 |
| 47 | Hypokalemia (HP:0002900) | 2.82351113 |
| 48 | Recurrent abscess formation (HP:0002722) | 2.80842836 |
| 49 | Slender build (HP:0001533) | 2.79596097 |
| 50 | Distal upper limb amyotrophy (HP:0007149) | 2.78516964 |
| 51 | Upper limb amyotrophy (HP:0009129) | 2.78516964 |
| 52 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.77668381 |
| 53 | Increased connective tissue (HP:0009025) | 2.73638312 |
| 54 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.72605893 |
| 55 | Generalized amyotrophy (HP:0003700) | 2.71682603 |
| 56 | Neurofibrillary tangles (HP:0002185) | 2.70738852 |
| 57 | Distal lower limb muscle weakness (HP:0009053) | 2.67014926 |
| 58 | Systemic lupus erythematosus (HP:0002725) | 2.63931041 |
| 59 | Abnormality of proline metabolism (HP:0010907) | 2.62087967 |
| 60 | Hydroxyprolinuria (HP:0003080) | 2.62087967 |
| 61 | Abnormality of dentin (HP:0010299) | 2.61348347 |
| 62 | Aortic dissection (HP:0002647) | 2.61339561 |
| 63 | Elbow flexion contracture (HP:0002987) | 2.60816510 |
| 64 | Natal tooth (HP:0000695) | 2.59131058 |
| 65 | Hypercalciuria (HP:0002150) | 2.58991689 |
| 66 | Bladder diverticulum (HP:0000015) | 2.58769374 |
| 67 | Hyperuricemia (HP:0002149) | 2.55465585 |
| 68 | Increased purine levels (HP:0004368) | 2.55465585 |
| 69 | Wormian bones (HP:0002645) | 2.53954803 |
| 70 | Abnormality of the umbilical cord (HP:0010881) | 2.52269960 |
| 71 | Amyloidosis (HP:0011034) | 2.51511145 |
| 72 | Glucose intolerance (HP:0000833) | 2.46374551 |
| 73 | Abnormality of glycolipid metabolism (HP:0010969) | 2.45433034 |
| 74 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.45433034 |
| 75 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.45433034 |
| 76 | Deep venous thrombosis (HP:0002625) | 2.43979255 |
| 77 | Nail dystrophy (HP:0008404) | 2.43461381 |
| 78 | Prostate neoplasm (HP:0100787) | 2.41244791 |
| 79 | Myocardial infarction (HP:0001658) | 2.39376727 |
| 80 | Difficulty climbing stairs (HP:0003551) | 2.38916414 |
| 81 | Blue sclerae (HP:0000592) | 2.38038818 |
| 82 | Abnormality of purine metabolism (HP:0004352) | 2.37580308 |
| 83 | Eczematoid dermatitis (HP:0000976) | 2.32257039 |
| 84 | Abnormality of potassium homeostasis (HP:0011042) | 2.31997758 |
| 85 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.30434270 |
| 86 | Disinhibition (HP:0000734) | 2.25738140 |
| 87 | Alopecia of scalp (HP:0002293) | 2.25477982 |
| 88 | Hand muscle atrophy (HP:0009130) | 2.24490008 |
| 89 | Hypophosphatemia (HP:0002148) | 2.23339579 |
| 90 | Proximal tubulopathy (HP:0000114) | 2.22416253 |
| 91 | Recurrent bacterial skin infections (HP:0005406) | 2.21153333 |
| 92 | Cerebral inclusion bodies (HP:0100314) | 2.20922106 |
| 93 | Glomerulonephritis (HP:0000099) | 2.20179097 |
| 94 | Plantar hyperkeratosis (HP:0007556) | 2.18584141 |
| 95 | Trismus (HP:0000211) | 2.18139871 |
| 96 | Cervical subluxation (HP:0003308) | 2.16045439 |
| 97 | Tubular atrophy (HP:0000092) | 2.15103376 |
| 98 | Genu recurvatum (HP:0002816) | 2.12187050 |
| 99 | Soft skin (HP:0000977) | 2.11141627 |
| 100 | Interstitial pulmonary disease (HP:0006530) | 2.10136756 |
| 101 | Lower limb amyotrophy (HP:0007210) | 2.09750742 |
| 102 | Aortic aneurysm (HP:0004942) | 2.06658549 |
| 103 | Abnormality of Sharpey fibers (HP:0100685) | 2.04691483 |
| 104 | Broad face (HP:0000283) | 2.03688336 |
| 105 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.03100629 |
| 106 | Single umbilical artery (HP:0001195) | 2.03100629 |
| 107 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.03100629 |
| 108 | Joint stiffness (HP:0001387) | 2.02844500 |
| 109 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.02339735 |
| 110 | Persistence of primary teeth (HP:0006335) | 2.00826050 |
| 111 | Thick nail (HP:0001805) | 2.00225573 |
| 112 | Limb-girdle muscle atrophy (HP:0003797) | 2.00217460 |
| 113 | Ankyloglossia (HP:0010296) | 1.97890700 |
| 114 | Dilatation of the ascending aorta (HP:0005111) | 1.96565093 |
| 115 | Adrenal overactivity (HP:0002717) | 1.96482672 |
| 116 | Abnormality of oral frenula (HP:0000190) | 1.95602713 |
| 117 | Increased variability in muscle fiber diameter (HP:0003557) | 1.95585709 |
| 118 | Pathologic fracture (HP:0002756) | 1.95204656 |
| 119 | Nuclear cataract (HP:0100018) | 1.94241305 |
| 120 | Hydroureter (HP:0000072) | 1.93373211 |
| 121 | Cardiovascular calcification (HP:0011915) | 1.93173022 |
| 122 | Chondrocalcinosis (HP:0000934) | 1.91928713 |
| 123 | Arterial tortuosity (HP:0005116) | 1.91681169 |
| 124 | Atrophic scars (HP:0001075) | 1.90970819 |
| 125 | Dehydration (HP:0001944) | 1.90552475 |
| 126 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89365964 |
| 127 | Osteolytic defects of the hand bones (HP:0009699) | 1.89365964 |
| 128 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.88055121 |
| 129 | Upper limb muscle weakness (HP:0003484) | 1.87660545 |
| 130 | Nephritis (HP:0000123) | 1.87484325 |
| 131 | Thin bony cortex (HP:0002753) | 1.87122759 |
| 132 | Peritonitis (HP:0002586) | 1.86602017 |
| 133 | Hyperglycinuria (HP:0003108) | 1.86367411 |
| 134 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.85652387 |
| 135 | Joint laxity (HP:0001388) | 1.85561017 |
| 136 | Mitral valve prolapse (HP:0001634) | 1.85502676 |
| 137 | Bone pain (HP:0002653) | 1.85178745 |
| 138 | Vascular tortuosity (HP:0004948) | 1.84104997 |
| 139 | Vascular calcification (HP:0004934) | 1.83968065 |
| 140 | Pterygium (HP:0001059) | 1.83615862 |
| 141 | Abnormality of sodium homeostasis (HP:0010931) | 1.82785729 |
| 142 | Protruding ear (HP:0000411) | 1.82392246 |
| 143 | Acanthosis nigricans (HP:0000956) | 1.81386655 |
| 144 | Rough bone trabeculation (HP:0100670) | 1.80887954 |
| 145 | Femoral bowing (HP:0002980) | 1.80679392 |
| 146 | Long toe (HP:0010511) | 1.80628173 |
| 147 | Nephrocalcinosis (HP:0000121) | 1.80324284 |
| 148 | Limb-girdle muscle weakness (HP:0003325) | 1.79799445 |
| 149 | Abnormal urine phosphate concentration (HP:0012599) | 1.79013392 |
| 150 | Obstructive lung disease (HP:0006536) | 1.78661769 |
| 151 | Chronic obstructive pulmonary disease (HP:0006510) | 1.78661769 |
| 152 | Selective tooth agenesis (HP:0001592) | 1.77767903 |
| 153 | Craniofacial hyperostosis (HP:0004493) | 1.77475164 |
| 154 | Hypoplasia of the iris (HP:0007676) | 1.77208789 |
| 155 | Osteopenia (HP:0000938) | 1.75245945 |
| 156 | Entropion (HP:0000621) | 1.74743101 |
| 157 | Spondylolisthesis (HP:0003302) | 1.74701847 |
| 158 | Cerebral aneurysm (HP:0004944) | 1.74103234 |
| 159 | Hyperacusis (HP:0010780) | 1.73698251 |
| 160 | Long palpebral fissure (HP:0000637) | 1.72161098 |
| 161 | Renal tubular dysfunction (HP:0000124) | 1.68399281 |
| 162 | Orchitis (HP:0100796) | 1.67817399 |
| 163 | Hypophosphatemic rickets (HP:0004912) | 1.65122309 |
| 164 | Gingivitis (HP:0000230) | 1.63823055 |
| 165 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.63567289 |
| 166 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.62787717 |
| 167 | J-shaped sella turcica (HP:0002680) | 1.60399760 |
| 168 | Vertebral compression fractures (HP:0002953) | 1.60191393 |
| 169 | Basal ganglia calcification (HP:0002135) | 1.60175056 |
| 170 | Stomatitis (HP:0010280) | 1.58519966 |
| 171 | Tubulointerstitial fibrosis (HP:0005576) | 1.57201409 |
| 172 | Thoracic kyphosis (HP:0002942) | 1.56650173 |
| 173 | Progressive visual loss (HP:0000529) | 1.56116214 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 5.56994583 |
| 2 | OXSR1 | 4.80418166 |
| 3 | WNK4 | 4.12143551 |
| 4 | TESK1 | 3.54225130 |
| 5 | TGFBR2 | 3.32540135 |
| 6 | LIMK1 | 3.31865062 |
| 7 | IRAK3 | 2.70438230 |
| 8 | NME2 | 2.67587388 |
| 9 | TTN | 2.67086950 |
| 10 | CASK | 2.60108357 |
| 11 | LMTK2 | 2.58956514 |
| 12 | TESK2 | 2.51310458 |
| 13 | MKNK2 | 2.35590458 |
| 14 | BLK | 2.04188150 |
| 15 | NTRK1 | 2.03854958 |
| 16 | KIT | 2.02346823 |
| 17 | ARAF | 2.02168759 |
| 18 | STK39 | 1.96105493 |
| 19 | PDGFRA | 1.94956962 |
| 20 | MAP3K14 | 1.87687450 |
| 21 | IRAK4 | 1.79641530 |
| 22 | SIK1 | 1.76705980 |
| 23 | TBK1 | 1.68895965 |
| 24 | TLK1 | 1.65559335 |
| 25 | MAP3K3 | 1.61690377 |
| 26 | TAOK2 | 1.54405681 |
| 27 | EPHB1 | 1.50699362 |
| 28 | LRRK2 | 1.45320547 |
| 29 | MST1R | 1.42395674 |
| 30 | VRK2 | 1.40685190 |
| 31 | CSK | 1.40256547 |
| 32 | PIK3CG | 1.38071583 |
| 33 | FES | 1.33774518 |
| 34 | MST4 | 1.28167759 |
| 35 | NEK9 | 1.25398960 |
| 36 | TYK2 | 1.25375865 |
| 37 | FLT3 | 1.25310843 |
| 38 | FER | 1.24754772 |
| 39 | PAK2 | 1.23829992 |
| 40 | ERN1 | 1.22814433 |
| 41 | GSK3A | 1.11189169 |
| 42 | MKNK1 | 1.11025249 |
| 43 | PIM2 | 1.07347753 |
| 44 | BMX | 1.07025372 |
| 45 | TAOK3 | 1.01979862 |
| 46 | IRAK1 | 0.99753737 |
| 47 | LATS2 | 0.98118979 |
| 48 | CDK8 | 0.97881376 |
| 49 | RIPK4 | 0.97869899 |
| 50 | CAMKK2 | 0.95658172 |
| 51 | PTK6 | 0.92961374 |
| 52 | MAP3K12 | 0.92645541 |
| 53 | PTK2 | 0.89932359 |
| 54 | IRAK2 | 0.89021549 |
| 55 | TRPM7 | 0.88627735 |
| 56 | STK10 | 0.88626841 |
| 57 | MAP2K3 | 0.86817795 |
| 58 | IKBKB | 0.86752076 |
| 59 | ICK | 0.85270433 |
| 60 | MOS | 0.84388035 |
| 61 | FGR | 0.83673829 |
| 62 | BUB1 | 0.83115978 |
| 63 | GRK5 | 0.82814608 |
| 64 | ROCK2 | 0.81703045 |
| 65 | TRIB3 | 0.79486376 |
| 66 | HCK | 0.78200348 |
| 67 | ABL2 | 0.75404665 |
| 68 | IKBKE | 0.75238616 |
| 69 | PRKD2 | 0.71696388 |
| 70 | WNK1 | 0.69471148 |
| 71 | SMG1 | 0.67805313 |
| 72 | ADRBK1 | 0.66931766 |
| 73 | NEK1 | 0.66399733 |
| 74 | EPHA2 | 0.65510572 |
| 75 | ILK | 0.65218268 |
| 76 | ABL1 | 0.63094343 |
| 77 | SGK223 | 0.62056529 |
| 78 | SGK494 | 0.62056529 |
| 79 | STK38 | 0.61413021 |
| 80 | PRPF4B | 0.60619920 |
| 81 | MAPK15 | 0.60608424 |
| 82 | DDR2 | 0.60224800 |
| 83 | PAK4 | 0.59946640 |
| 84 | ROCK1 | 0.59370502 |
| 85 | PBK | 0.59108329 |
| 86 | CAMK1D | 0.57347873 |
| 87 | SCYL2 | 0.56411534 |
| 88 | CSF1R | 0.55636701 |
| 89 | MAP3K8 | 0.55455738 |
| 90 | CAMK1G | 0.55245986 |
| 91 | RIPK1 | 0.54722355 |
| 92 | LCK | 0.54174913 |
| 93 | PRKG2 | 0.53538647 |
| 94 | DYRK1B | 0.53297311 |
| 95 | RPS6KA4 | 0.52659191 |
| 96 | JAK1 | 0.52362090 |
| 97 | MAP3K11 | 0.51140959 |
| 98 | DAPK1 | 0.51101477 |
| 99 | CDC42BPA | 0.48755952 |
| 100 | MYLK | 0.48746923 |
| 101 | GRK7 | 0.47984618 |
| 102 | CDK6 | 0.47539279 |
| 103 | PRKAA2 | 0.46479785 |
| 104 | PRKCD | 0.45650198 |
| 105 | MATK | 0.45173377 |
| 106 | MAPKAPK2 | 0.45015834 |
| 107 | SIK3 | 0.44840162 |
| 108 | STK3 | 0.44596656 |
| 109 | LYN | 0.44468097 |
| 110 | ERBB4 | 0.44325372 |
| 111 | LATS1 | 0.43642801 |
| 112 | BRAF | 0.42303308 |
| 113 | AURKA | 0.41214430 |
| 114 | DMPK | 0.40778508 |
| 115 | MAP2K2 | 0.40274908 |
| 116 | JAK2 | 0.40081998 |
| 117 | PHKG1 | 0.39761886 |
| 118 | PHKG2 | 0.39761886 |
| 119 | EGFR | 0.38805250 |
| 120 | PDGFRB | 0.38645548 |
| 121 | CHUK | 0.37870807 |
| 122 | BRSK1 | 0.37610631 |
| 123 | DAPK3 | 0.37164658 |
| 124 | EPHB2 | 0.36979576 |
| 125 | TEC | 0.36967842 |
| 126 | SGK3 | 0.36344575 |
| 127 | PAK1 | 0.36189467 |
| 128 | ZAP70 | 0.36064056 |
| 129 | INSR | 0.35353718 |
| 130 | PKN1 | 0.35270273 |
| 131 | MET | 0.35169750 |
| 132 | PTK2B | 0.34392881 |
| 133 | KDR | 0.34207625 |
| 134 | SGK2 | 0.34170162 |
| 135 | ITK | 0.34096765 |
| 136 | EIF2AK2 | 0.32887299 |
| 137 | HIPK2 | 0.32740666 |
| 138 | NLK | 0.32645864 |
| 139 | RPS6KA2 | 0.31306794 |
| 140 | MAP3K13 | 0.30249113 |
| 141 | MTOR | 0.30201576 |
| 142 | CDK7 | 0.29041591 |
| 143 | CAMK2G | 0.26850270 |
| 144 | PRKCI | 0.24562539 |
| 145 | MAPKAPK3 | 0.24283685 |
| 146 | CDK9 | 0.23834529 |
| 147 | CDK18 | 0.23292316 |
| 148 | CDK14 | 0.23084522 |
| 149 | MELK | 0.22747929 |
| 150 | CDK15 | 0.22297420 |
| 151 | MAP3K1 | 0.22142985 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.06132834 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.51688346 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 3.08952048 |
| 4 | Malaria_Homo sapiens_hsa05144 | 2.44321625 |
| 5 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.32643181 |
| 6 | Phagosome_Homo sapiens_hsa04145 | 2.23675853 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.14924574 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.12080795 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.11386516 |
| 10 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.03806292 |
| 11 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.03533374 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.01092172 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.93959110 |
| 14 | Galactose metabolism_Homo sapiens_hsa00052 | 1.87417062 |
| 15 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.87384713 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.81321343 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.80016013 |
| 18 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.76734292 |
| 19 | Proteasome_Homo sapiens_hsa03050 | 1.74572801 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.71908182 |
| 21 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.69933509 |
| 22 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.67656681 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.58240573 |
| 24 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.53493603 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.51729271 |
| 26 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.51353225 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.50632649 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.45335565 |
| 29 | Focal adhesion_Homo sapiens_hsa04510 | 1.42152041 |
| 30 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.41397377 |
| 31 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.40239480 |
| 32 | Mineral absorption_Homo sapiens_hsa04978 | 1.36634676 |
| 33 | Amoebiasis_Homo sapiens_hsa05146 | 1.34344861 |
| 34 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.33696747 |
| 35 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.29148843 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.28528815 |
| 37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.23369654 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.22268076 |
| 39 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.19589609 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.16215126 |
| 41 | Prion diseases_Homo sapiens_hsa05020 | 1.15851577 |
| 42 | Thyroid cancer_Homo sapiens_hsa05216 | 1.14899945 |
| 43 | Adherens junction_Homo sapiens_hsa04520 | 1.13710388 |
| 44 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.13710173 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13200031 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12668477 |
| 47 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.12660758 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07623403 |
| 49 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.06787826 |
| 50 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.04954109 |
| 51 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.04226295 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03372162 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 1.02289467 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.00980360 |
| 55 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.99940244 |
| 56 | Shigellosis_Homo sapiens_hsa05131 | 0.98329925 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.94353845 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93436137 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 0.90978320 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.90613122 |
| 61 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.89076196 |
| 62 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.87820593 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.86781748 |
| 64 | Melanoma_Homo sapiens_hsa05218 | 0.85831550 |
| 65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.85105338 |
| 66 | Apoptosis_Homo sapiens_hsa04210 | 0.85032087 |
| 67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.84960103 |
| 68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83312305 |
| 69 | Measles_Homo sapiens_hsa05162 | 0.81889159 |
| 70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81516024 |
| 71 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.80677361 |
| 72 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.79112850 |
| 73 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78720348 |
| 74 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.77783709 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.76789879 |
| 76 | Pathways in cancer_Homo sapiens_hsa05200 | 0.76746055 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.74004140 |
| 78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73390462 |
| 79 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.71122454 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70912915 |
| 81 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.69951671 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69638961 |
| 83 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.69396239 |
| 84 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69043204 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | 0.68512616 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68349898 |
| 87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67409313 |
| 88 | Prostate cancer_Homo sapiens_hsa05215 | 0.66662415 |
| 89 | Asthma_Homo sapiens_hsa05310 | 0.66415409 |
| 90 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.64480516 |
| 91 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.64464592 |
| 92 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63793415 |
| 93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63512759 |
| 94 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.63463708 |
| 95 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63184704 |
| 96 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62810720 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62199118 |
| 98 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.61584428 |
| 99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.61311151 |
| 100 | Legionellosis_Homo sapiens_hsa05134 | 0.60552690 |
| 101 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.58816029 |
| 102 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58049183 |
| 103 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.57911079 |
| 104 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.57176807 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57032322 |
| 106 | Bile secretion_Homo sapiens_hsa04976 | 0.55337770 |
| 107 | Influenza A_Homo sapiens_hsa05164 | 0.54751020 |
| 108 | Platelet activation_Homo sapiens_hsa04611 | 0.54530266 |
| 109 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53585703 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53531316 |
| 111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53448471 |
| 112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52930652 |
| 113 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52594798 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52518283 |
| 115 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.52199824 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51897181 |
| 117 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51231950 |
| 118 | Glioma_Homo sapiens_hsa05214 | 0.50295377 |
| 119 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.49938457 |
| 120 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.49684256 |
| 121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48797326 |
| 122 | Axon guidance_Homo sapiens_hsa04360 | 0.47720586 |
| 123 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47081268 |
| 124 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47070551 |
| 125 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47014703 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.45903482 |
| 127 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.45112625 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44313716 |
| 129 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44066846 |
| 130 | Lysine degradation_Homo sapiens_hsa00310 | 0.43450161 |
| 131 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.43059675 |
| 132 | Hepatitis B_Homo sapiens_hsa05161 | 0.43048987 |
| 133 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42198799 |
| 134 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41897016 |
| 135 | Tight junction_Homo sapiens_hsa04530 | 0.41119118 |
| 136 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.40226900 |
| 137 | Allograft rejection_Homo sapiens_hsa05330 | 0.40020280 |
| 138 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39601127 |
| 139 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38764339 |
| 140 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38585982 |
| 141 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38490522 |
| 142 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.38286627 |
| 143 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.37600468 |
| 144 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36932686 |

